KR20020004944A - 정량조절 및 배출 장치 - Google Patents

정량조절 및 배출 장치 Download PDF

Info

Publication number: KR20020004944A
Authority: KR; South Korea
Prior art keywords: piston; valve; fluid; shaft; reservoir
Prior art date: 1999-01-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

KR1020017008745A

Other languages

English (en)

Korean (ko)

Inventor

캔데이비드빅터

Original Assignee

데이비드 엠 모이어

더 프록터 앤드 갬블 캄파니

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-13

Filing date

2000-01-12

Publication date

2002-01-16

2000-01-12 Application filed by 데이비드 엠 모이어, 더 프록터 앤드 갬블 캄파니 filed Critical 데이비드 엠 모이어

2002-01-16 Publication of KR20020004944A publication Critical patent/KR20020004944A/ko

Status Ceased legal-status Critical Current

Links

239000012530 fluid Substances 0.000 claims abstract description 103
238000007789 sealing Methods 0.000 claims abstract description 9
238000006073 displacement reaction Methods 0.000 claims abstract description 8
238000004891 communication Methods 0.000 claims description 7
230000006835 compression Effects 0.000 claims description 5
238000007906 compression Methods 0.000 claims description 5
239000004020 conductor Substances 0.000 claims description 2
230000007423 decrease Effects 0.000 claims 1
230000002829 reductive effect Effects 0.000 abstract description 6
239000003814 drug Substances 0.000 description 28
239000007921 spray Substances 0.000 description 22
239000000203 mixture Substances 0.000 description 20
239000007788 liquid Substances 0.000 description 19
-1 tetrahydrazoline Chemical compound 0.000 description 15
150000003839 salts Chemical class 0.000 description 13
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
229940079593 drug Drugs 0.000 description 9
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
239000002562 thickening agent Substances 0.000 description 8
229920001971 elastomer Polymers 0.000 description 6
239000000806 elastomer Substances 0.000 description 6
210000001331 nose Anatomy 0.000 description 6
239000002245 particle Substances 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
239000000080 wetting agent Substances 0.000 description 6
239000000739 antihistaminic agent Substances 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
239000003205 fragrance Substances 0.000 description 5
239000003755 preservative agent Substances 0.000 description 5
238000005507 spraying Methods 0.000 description 5
239000004094 surface-active agent Substances 0.000 description 5
KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 4
229940125715 antihistaminic agent Drugs 0.000 description 4
239000000850 decongestant Substances 0.000 description 4
238000007599 discharging Methods 0.000 description 4
239000006185 dispersion Substances 0.000 description 4
230000005684 electric field Effects 0.000 description 4
239000000839 emulsion Substances 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
239000000463 material Substances 0.000 description 4
239000012528 membrane Substances 0.000 description 4
238000000034 method Methods 0.000 description 4
210000003928 nasal cavity Anatomy 0.000 description 4
WYWIFABBXFUGLM-UHFFFAOYSA-N oxymetazoline Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 WYWIFABBXFUGLM-UHFFFAOYSA-N 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
206010057190 Respiratory tract infections Diseases 0.000 description 3
GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical group C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 3
HUCJFAOMUPXHDK-UHFFFAOYSA-N Xylometazoline Chemical compound CC1=CC(C(C)(C)C)=CC(C)=C1CC1=NCCN1 HUCJFAOMUPXHDK-UHFFFAOYSA-N 0.000 description 3
229940121363 anti-inflammatory agent Drugs 0.000 description 3
239000002260 anti-inflammatory agent Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 3
229940124581 decongestants Drugs 0.000 description 3
WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
239000003921 oil Substances 0.000 description 3
230000036961 partial effect Effects 0.000 description 3
229920001296 polysiloxane Polymers 0.000 description 3
229920002379 silicone rubber Polymers 0.000 description 3
CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 description 2
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
235000011437 Amygdalus communis Nutrition 0.000 description 2
244000144725 Amygdalus communis Species 0.000 description 2
241000167854 Bourreria succulenta Species 0.000 description 2
WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 2
235000005979 Citrus limon Nutrition 0.000 description 2
244000131522 Citrus pyriformis Species 0.000 description 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
229920002125 Sokalan® Polymers 0.000 description 2
ZZHLYYDVIOPZBE-UHFFFAOYSA-N Trimeprazine Chemical compound C1=CC=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1 ZZHLYYDVIOPZBE-UHFFFAOYSA-N 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
150000001299 aldehydes Chemical class 0.000 description 2
235000020224 almond Nutrition 0.000 description 2
229940035676 analgesics Drugs 0.000 description 2
239000000730 antalgic agent Substances 0.000 description 2
HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
229960000686 benzalkonium chloride Drugs 0.000 description 2
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
239000002738 chelating agent Substances 0.000 description 2
235000019693 cherries Nutrition 0.000 description 2
YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 2
229960003333 chlorhexidine gluconate Drugs 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
235000020971 citrus fruits Nutrition 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000013536 elastomeric material Substances 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
229960002179 ephedrine Drugs 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
229960004305 lodoxamide Drugs 0.000 description 2
RVGLGHVJXCETIO-UHFFFAOYSA-N lodoxamide Chemical compound OC(=O)C(=O)NC1=CC(C#N)=CC(NC(=O)C(O)=O)=C1Cl RVGLGHVJXCETIO-UHFFFAOYSA-N 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
229960001528 oxymetazoline Drugs 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
229940044551 receptor antagonist Drugs 0.000 description 2
239000002464 receptor antagonist Substances 0.000 description 2
239000001509 sodium citrate Substances 0.000 description 2
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000000600 sorbitol Substances 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 description 1
DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
CBOBADCVMLMQRW-UHFFFAOYSA-N 2,6-dimethyloctanal Chemical compound CCC(C)CCCC(C)C=O CBOBADCVMLMQRW-UHFFFAOYSA-N 0.000 description 1
DPPDPATYPQFYDL-UHFFFAOYSA-N 2-[2-(dimethylamino)ethyl]-4-methyl-2,3-dihydropyrido[3,2-f][1,4]oxazepine-5-thione Chemical compound O1C(CCN(C)C)CN(C)C(=S)C2=CC=CN=C21 DPPDPATYPQFYDL-UHFFFAOYSA-N 0.000 description 1
SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
JTOUASWUIMAMAD-UHFFFAOYSA-N 7-[2-hydroxy-3-[4-(3-phenylsulfanylpropyl)piperazin-1-yl]propyl]-1,3-dimethylpurine-2,6-dione Chemical compound C1=2C(=O)N(C)C(=O)N(C)C=2N=CN1CC(O)CN(CC1)CCN1CCCSC1=CC=CC=C1 JTOUASWUIMAMAD-UHFFFAOYSA-N 0.000 description 1
PFWLFWPASULGAN-UHFFFAOYSA-N 7-methylxanthine Chemical compound N1C(=O)NC(=O)C2=C1N=CN2C PFWLFWPASULGAN-UHFFFAOYSA-N 0.000 description 1
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 description 1
VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
229920001661 Chitosan Polymers 0.000 description 1
241000723346 Cinnamomum camphora Species 0.000 description 1
241000207199 Citrus Species 0.000 description 1
235000008733 Citrus aurantifolia Nutrition 0.000 description 1
241001672694 Citrus reticulata Species 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 description 1
102000003820 Lipoxygenases Human genes 0.000 description 1
108090000128 Lipoxygenases Proteins 0.000 description 1
239000004944 Liquid Silicone Rubber Substances 0.000 description 1
OCJYIGYOJCODJL-UHFFFAOYSA-N Meclizine Chemical compound CC1=CC=CC(CN2CCN(CC2)C(C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 OCJYIGYOJCODJL-UHFFFAOYSA-N 0.000 description 1
HOKDBMAJZXIPGC-UHFFFAOYSA-N Mequitazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CC1C(CC2)CCN2C1 HOKDBMAJZXIPGC-UHFFFAOYSA-N 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
ISFHAYSTHMVOJR-UHFFFAOYSA-N Phenindamine Chemical compound C1N(C)CCC(C2=CC=CC=C22)=C1C2C1=CC=CC=C1 ISFHAYSTHMVOJR-UHFFFAOYSA-N 0.000 description 1
239000005062 Polybutadiene Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
244000178231 Rosmarinus officinalis Species 0.000 description 1
240000002657 Thymus vulgaris Species 0.000 description 1
235000007303 Thymus vulgaris Nutrition 0.000 description 1
235000011941 Tilia x europaea Nutrition 0.000 description 1
UFLGIAIHIAPJJC-UHFFFAOYSA-N Tripelennamine Chemical compound C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CC=C1 UFLGIAIHIAPJJC-UHFFFAOYSA-N 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
229960003792 acrivastine Drugs 0.000 description 1
PWACSDKDOHSSQD-IUTFFREVSA-N acrivastine Chemical compound C1=CC(C)=CC=C1C(\C=1N=C(\C=C\C(O)=O)C=CC=1)=C/CN1CCCC1 PWACSDKDOHSSQD-IUTFFREVSA-N 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
229960003790 alimemazine Drugs 0.000 description 1
150000003973 alkyl amines Chemical class 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
230000001387 anti-histamine Effects 0.000 description 1
230000001166 anti-perspirative effect Effects 0.000 description 1
230000001754 anti-pyretic effect Effects 0.000 description 1
239000000043 antiallergic agent Substances 0.000 description 1
229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
239000000935 antidepressant agent Substances 0.000 description 1
229940005513 antidepressants Drugs 0.000 description 1
239000003213 antiperspirant Substances 0.000 description 1
239000002221 antipyretic Substances 0.000 description 1
229940125716 antipyretic agent Drugs 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
238000000889 atomisation Methods 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
229960000383 azatadine Drugs 0.000 description 1
SEBMTIQKRHYNIT-UHFFFAOYSA-N azatadine Chemical compound C1CN(C)CCC1=C1C2=NC=CC=C2CCC2=CC=CC=C21 SEBMTIQKRHYNIT-UHFFFAOYSA-N 0.000 description 1
229960004574 azelastine Drugs 0.000 description 1
NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
229940092705 beclomethasone Drugs 0.000 description 1
229940095076 benzaldehyde Drugs 0.000 description 1
YNKMHABLMGIIFX-UHFFFAOYSA-N benzaldehyde;methane Chemical compound C.O=CC1=CC=CC=C1 YNKMHABLMGIIFX-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
229960000725 brompheniramine Drugs 0.000 description 1
ZDIGNSYAACHWNL-UHFFFAOYSA-N brompheniramine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Br)C=C1 ZDIGNSYAACHWNL-UHFFFAOYSA-N 0.000 description 1
229960004436 budesonide Drugs 0.000 description 1
239000000872 buffer Substances 0.000 description 1
229920005549 butyl rubber Polymers 0.000 description 1
229960001948 caffeine Drugs 0.000 description 1
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
229930008380 camphor Natural products 0.000 description 1
229960000846 camphor Drugs 0.000 description 1
229960000428 carbinoxamine Drugs 0.000 description 1
OJFSXZCBGQGRNV-UHFFFAOYSA-N carbinoxamine Chemical compound C=1C=CC=NC=1C(OCCN(C)C)C1=CC=C(Cl)C=C1 OJFSXZCBGQGRNV-UHFFFAOYSA-N 0.000 description 1
229960001631 carbomer Drugs 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
229960001803 cetirizine Drugs 0.000 description 1
238000001311 chemical methods and process Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
229960003291 chlorphenamine Drugs 0.000 description 1
SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
239000000812 cholinergic antagonist Substances 0.000 description 1
229960005233 cineole Drugs 0.000 description 1
229940043350 citral Drugs 0.000 description 1
WTEVQBCEXWBHNA-YFHOEESVSA-N citral B Natural products CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 description 1
229960002881 clemastine Drugs 0.000 description 1
YNNUSGIPVFPVBX-NHCUHLMSSA-N clemastine Chemical compound CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 YNNUSGIPVFPVBX-NHCUHLMSSA-N 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000011109 contamination Methods 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
229960000265 cromoglicic acid Drugs 0.000 description 1
229960001140 cyproheptadine Drugs 0.000 description 1
JJCFRYNCJDLXIK-UHFFFAOYSA-N cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 1
230000006837 decompression Effects 0.000 description 1
229960000520 diphenhydramine Drugs 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 1
235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
229960005178 doxylamine Drugs 0.000 description 1
HCFDWZZGGLSKEP-UHFFFAOYSA-N doxylamine Chemical compound C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 HCFDWZZGGLSKEP-UHFFFAOYSA-N 0.000 description 1
238000005553 drilling Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
229960001971 ebastine Drugs 0.000 description 1
MJJALKDDGIKVBE-UHFFFAOYSA-N ebastine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(=O)CCCN1CCC(OC(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 MJJALKDDGIKVBE-UHFFFAOYSA-N 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
238000004945 emulsification Methods 0.000 description 1
229960005293 etodolac Drugs 0.000 description 1
XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 1
239000003172 expectorant agent Substances 0.000 description 1
229960001419 fenoprofen Drugs 0.000 description 1
239000010419 fine particle Substances 0.000 description 1
229960000676 flunisolide Drugs 0.000 description 1
229960002390 flurbiprofen Drugs 0.000 description 1
SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
229960002714 fluticasone Drugs 0.000 description 1
MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 1
239000004088 foaming agent Substances 0.000 description 1
MCPSMQGVSYDFLC-UHFFFAOYSA-N formaldehyde;2-octylphenol Chemical group O=C.CCCCCCCCC1=CC=CC=C1O MCPSMQGVSYDFLC-UHFFFAOYSA-N 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
210000003630 histaminocyte Anatomy 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
ZQDWXGKKHFNSQK-UHFFFAOYSA-N hydroxyzine Chemical compound C1CN(CCOCCO)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZQDWXGKKHFNSQK-UHFFFAOYSA-N 0.000 description 1
229960000930 hydroxyzine Drugs 0.000 description 1
229960001680 ibuprofen Drugs 0.000 description 1
229960000905 indomethacin Drugs 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
230000007794 irritation Effects 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
229960000991 ketoprofen Drugs 0.000 description 1
229960004752 ketorolac Drugs 0.000 description 1
OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 1
229960004958 ketotifen Drugs 0.000 description 1
229940065725 leukotriene receptor antagonists for obstructive airway diseases Drugs 0.000 description 1
239000003199 leukotriene receptor blocking agent Substances 0.000 description 1
229960001120 levocabastine Drugs 0.000 description 1
ZCGOMHNNNFPNMX-KYTRFIICSA-N levocabastine Chemical compound C1([C@@]2(C(O)=O)CCN(C[C@H]2C)[C@@H]2CC[C@@](CC2)(C#N)C=2C=CC(F)=CC=2)=CC=CC=C1 ZCGOMHNNNFPNMX-KYTRFIICSA-N 0.000 description 1
210000003041 ligament Anatomy 0.000 description 1
239000004571 lime Substances 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000012705 liquid precursor Substances 0.000 description 1
229960003088 loratadine Drugs 0.000 description 1
JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
229960001474 meclozine Drugs 0.000 description 1
229960000582 mepyramine Drugs 0.000 description 1
YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 1
229960005042 mequitazine Drugs 0.000 description 1
229960004056 methdilazine Drugs 0.000 description 1
HTMIBDQKFHUPSX-UHFFFAOYSA-N methdilazine Chemical compound C1N(C)CCC1CN1C2=CC=CC=C2SC2=CC=CC=C21 HTMIBDQKFHUPSX-UHFFFAOYSA-N 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
239000003607 modifier Substances 0.000 description 1
230000000510 mucolytic effect Effects 0.000 description 1
229940066491 mucolytics Drugs 0.000 description 1
229960005016 naphazoline Drugs 0.000 description 1
229960002009 naproxen Drugs 0.000 description 1
CMWTZPSULFXXJA-VIFPVBQESA-M naproxen(1-) Chemical compound C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-M 0.000 description 1
229960004398 nedocromil Drugs 0.000 description 1
RQTOOFIXOKYGAN-UHFFFAOYSA-N nedocromil Chemical compound CCN1C(C(O)=O)=CC(=O)C2=C1C(CCC)=C1OC(C(O)=O)=CC(=O)C1=C2 RQTOOFIXOKYGAN-UHFFFAOYSA-N 0.000 description 1
229960002715 nicotine Drugs 0.000 description 1
SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
239000012811 non-conductive material Substances 0.000 description 1
GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
230000000631 nonopiate Effects 0.000 description 1
NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
229960002698 oxatomide Drugs 0.000 description 1
BAINIUMDFURPJM-UHFFFAOYSA-N oxatomide Chemical compound O=C1NC2=CC=CC=C2N1CCCN(CC1)CCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 BAINIUMDFURPJM-UHFFFAOYSA-N 0.000 description 1
229960005162 oxymetazoline hydrochloride Drugs 0.000 description 1
BEEDODBODQVSIM-UHFFFAOYSA-N oxymetazoline hydrochloride Chemical compound Cl.CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 BEEDODBODQVSIM-UHFFFAOYSA-N 0.000 description 1
QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
229960005489 paracetamol Drugs 0.000 description 1
239000008177 pharmaceutical agent Substances 0.000 description 1
229960003534 phenindamine Drugs 0.000 description 1
229950000688 phenothiazine Drugs 0.000 description 1
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
229960001802 phenylephrine Drugs 0.000 description 1
SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
229940067107 phenylethyl alcohol Drugs 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
229920001084 poly(chloroprene) Polymers 0.000 description 1
229920002857 polybutadiene Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229940068968 polysorbate 80 Drugs 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
229960003910 promethazine Drugs 0.000 description 1
KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
229960003908 pseudoephedrine Drugs 0.000 description 1
238000004080 punching Methods 0.000 description 1
MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
239000012858 resilient material Substances 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
229950003786 rocastine Drugs 0.000 description 1
229920002631 room-temperature vulcanizate silicone Polymers 0.000 description 1
239000010668 rosemary oil Substances 0.000 description 1
239000010670 sage oil Substances 0.000 description 1
229950003911 setastine Drugs 0.000 description 1
VBSPHZOBAOWFCL-UHFFFAOYSA-N setastine Chemical compound C=1C=CC=CC=1C(C=1C=CC(Cl)=CC=1)(C)OCCN1CCCCCC1 VBSPHZOBAOWFCL-UHFFFAOYSA-N 0.000 description 1
229920002545 silicone oil Polymers 0.000 description 1
HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
229910001415 sodium ion Inorganic materials 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000001433 sodium tartrate Substances 0.000 description 1
229960002167 sodium tartrate Drugs 0.000 description 1
235000011004 sodium tartrates Nutrition 0.000 description 1
239000000243 solution Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
235000013599 spices Nutrition 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000003068 static effect Effects 0.000 description 1
229920003048 styrene butadiene rubber Polymers 0.000 description 1
239000000126 substance Substances 0.000 description 1
229950004607 tazifylline Drugs 0.000 description 1
229960000351 terfenadine Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
229920002725 thermoplastic elastomer Polymers 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
239000010678 thyme oil Substances 0.000 description 1
229960001262 tramazoline Drugs 0.000 description 1
QQJLHRRUATVHED-UHFFFAOYSA-N tramazoline Chemical compound N1CCN=C1NC1=CC=CC2=C1CCCC2 QQJLHRRUATVHED-UHFFFAOYSA-N 0.000 description 1
229960003223 tripelennamine Drugs 0.000 description 1
229960001128 triprolidine Drugs 0.000 description 1
CBEQULMOCCWAQT-WOJGMQOQSA-N triprolidine Chemical compound C1=CC(C)=CC=C1C(\C=1N=CC=CC=1)=C/CN1CCCC1 CBEQULMOCCWAQT-WOJGMQOQSA-N 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
229920001664 tyloxapol Polymers 0.000 description 1
229960004224 tyloxapol Drugs 0.000 description 1
MDYZKJNTKZIUSK-UHFFFAOYSA-N tyloxapol Chemical compound O=C.C1CO1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 MDYZKJNTKZIUSK-UHFFFAOYSA-N 0.000 description 1
239000000230 xanthan gum Substances 0.000 description 1
235000010493 xanthan gum Nutrition 0.000 description 1
229920001285 xanthan gum Polymers 0.000 description 1
229940082509 xanthan gum Drugs 0.000 description 1
229960000833 xylometazoline Drugs 0.000 description 1

Classifications

- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
- B05B5/025—Discharge apparatus, e.g. electrostatic spray guns
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
- B05B11/028—Pistons separating the content remaining in the container from the atmospheric air to compensate underpressure inside the container
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1001—Piston pumps
- B05B11/1015—Piston pumps actuated without substantial movement of the nozzle in the direction of the pressure stroke
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1042—Components or details
- B05B11/1052—Actuation means
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1094—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle having inlet or outlet valves not being actuated by pressure or having no inlet or outlet valve
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
- B05B5/16—Arrangements for supplying liquids or other fluent material
- B05B5/1691—Apparatus to be carried on or by a person or with a container fixed to the discharge device

Landscapes

Medicinal Preparation (AREA)
Devices For Dispensing Beverages (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Reciprocating Pumps (AREA)
Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
Loading And Unloading Of Fuel Tanks Or Ships (AREA)
Devices For Use In Laboratory Experiments (AREA)
Sampling And Sample Adjustment (AREA)
Vehicle Body Suspensions (AREA)

KR1020017008745A 1999-01-13 2000-01-12 정량조절 및 배출 장치 Ceased KR20020004944A (ko)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP99870004.1		1999-01-13
EP99870004A EP1020233A1 (fr)	1999-01-13	1999-01-13	Système de dosage et de distribution
PCT/US2000/000834 WO2000041816A1 (fr)	1999-01-13	2000-01-12	Systeme de dosage et de distribution

Publications (1)

Publication Number	Publication Date
KR20020004944A true KR20020004944A (ko)	2002-01-16

Family

ID=8243788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1020017008745A Ceased KR20020004944A (ko)	1999-01-13	2000-01-12	정량조절 및 배출 장치

Country Status (23)

Country	Link
EP (2)	EP1020233A1 (fr)
JP (1)	JP4295437B2 (fr)
KR (1)	KR20020004944A (fr)
CN (1)	CN1347346A (fr)
AT (1)	ATE248030T1 (fr)
AU (1)	AU748289B2 (fr)
BR (1)	BR0007526A (fr)
CA (1)	CA2360411A1 (fr)
CO (1)	CO5231171A1 (fr)
CZ (1)	CZ20012506A3 (fr)
DE (1)	DE60004780T2 (fr)
EG (1)	EG22672A (fr)
HU (1)	HUP0105057A3 (fr)
IL (1)	IL144092A0 (fr)
MA (1)	MA25341A1 (fr)
NO (1)	NO20013508D0 (fr)
NZ (1)	NZ512600A (fr)
PE (1)	PE20001192A1 (fr)
PL (1)	PL349767A1 (fr)
RU (1)	RU2198740C1 (fr)
SK (1)	SK10062001A3 (fr)
WO (1)	WO2000041816A1 (fr)
ZA (1)	ZA200105289B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101498220B1 (ko) *	2013-08-30	2015-03-03	삼성중공업 주식회사	체결부 부식방지용 실링 장치

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
US6951295B1 (en) *	2005-01-18	2005-10-04	Seaquist Closures Foreign, Inc.	Flow control element and dispensing structure incorporating same
FR2893090A1 (fr) *	2005-11-09	2007-05-11	Claude Jaunay	Ensemble de pompage et de distribution de fluide
NL1030992C2 (nl)	2006-01-24	2007-07-26	Airspray Nv	Knijpschuimvormer.
NL1030993C2 (nl) *	2006-01-24	2007-07-26	Airspray Nv	Knijpschuimvormer.
JP5143749B2 (ja) *	2006-01-24	2013-02-13	レクサムエアースプレーエヌブイ	吐出装置
GB0602980D0 (en)	2006-02-14	2006-03-29	Optinose As	Delivery device and method
WO2010045186A2 (fr) *	2008-10-16	2010-04-22	Automatic Bar Controls, Inc.	Dispositif et procédé et plateau tournant pour distribuer un produit alimentaire sur demande
EP2201977A1 (fr) *	2008-12-23	2010-06-30	Siegfried Generics International AG	Dispositif de dosage destiné à la production d'un flux de gaz à l'aide d'une matière active répartie finement
RU2452585C2 (ru) *	2009-06-03	2012-06-10	Макнейл Аб	Карманное распределительное устройство
JP5430769B2 (ja) *	2009-10-08	2014-03-05	エス・ホー・エル・グループ・アクチボラゲット	計量液滴吸入器
RU2529397C2 (ru) *	2012-10-04	2014-09-27	Ирина Леонидовна Лисовская	Устройство для электрофореза лекарственного вещества в ткани глаза
GB2507313B (en) *	2012-10-25	2015-09-30	Tristel Plc	Pump apparatus
JP5992321B2 (ja) *	2012-12-27	2016-09-14	株式会社吉野工業所	シリンジ型噴出容器
US11554229B2 (en)	2013-03-26	2023-01-17	OptiNose Inc.	Nasal administration
DE102013013530A1 (de) *	2013-08-13	2015-03-12	Dürr Systems GmbH	Applikationssystem mit seilgeführter Handhabungsvorrichtung zum Bewegen eines Applikationsgeräts
CN108704200A (zh) *	2015-05-16	2018-10-26	苏州汉方医药有限公司	由手动悬浮微颗粒发生器和白花蛇舌草或白花蛇舌草素组成的药盒
GB2553031B (en)	2017-06-27	2021-12-29	Kohler Mira Ltd	Additive dispenser
DE102018121513B4 (de) *	2018-09-04	2020-04-02	Prof. Reymond & Hetzel GbR (vertretungsberechtigter Gesellschafter: Alexander Hetzel, 78667 Villingendorf)	Medizinisches Instrument zum gerichteten Einbringen einer Substanz in einen Hohlraum eines Körpers und Werkzeug dafür
US11666931B2 (en)	2019-05-14	2023-06-06	Kohler Co.	Inline shower device
US12031306B2 (en)	2019-05-14	2024-07-09	Kohler Co.	Inline dispensing device
USD1090783S1 (en)	2020-04-24	2025-08-26	Kohler Co.	Shower system
EP3935972B1 (fr) *	2020-07-07	2023-09-06	Aptar Radolfzell GmbH	Distributeur oral pour liquides, en particulier pour des liquides contenant de la nicotine ou du cannabis
USD1104211S1 (en)	2021-07-01	2025-12-02	Kohler Co.	Shower system
USD1104210S1 (en)	2021-07-01	2025-12-02	Kohler Co.	Shower device

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR920943A (fr) *	1946-01-30	1947-04-22		éjecteur pour liquides
DE3339180C2 (de) *	1983-10-28	1993-10-14	Pfeiffer Erich Gmbh & Co Kg	Austragvorrichtung für Medien
US4728006A (en)	1984-04-27	1988-03-01	The Procter & Gamble Company	Flexible container including self-sealing dispensing valve to provide automatic shut-off and leak resistant inverted storage
FR2580956A1 (fr) *	1985-04-24	1986-10-31	Wassilieff Victor	Recipient pour la diffusion sous pression d'un fluide
DE3900267A1 (de) *	1989-01-07	1990-07-12	Alfred Von Schuckmann	Spender
US4991745A (en)	1989-04-25	1991-02-12	Liquid Molding Systems, Inc.	Dispensing valve with trampoline-like construction
WO1993002729A1 (fr) *	1990-07-12	1993-02-18	Habley Medical Technology Corporation	Inhalateur de medicaments a atomisation tres fine, contenant du fluorocarbone non chlore
DK302890D0 (da)	1990-12-21	1990-12-21	Novo Nordisk As	Dispenser
EP0597601A1 (fr)	1992-11-13	1994-05-18	National Semiconductor Corporation	Interface de bus de mémoire avec dimensionnement réfléchi
EP0780127A1 (fr)	1995-12-19	1997-06-25	The Procter & Gamble Company	Pulvérisateur nasale contenant un stéréoide et un antihistamine
BR9709650A (pt)	1996-06-04	1999-08-10	Procter & Gamble	Aerosol nasal contendo um esteróide intransal e um anti-histamínico
GB9619445D0 (en) *	1996-09-18	1996-10-30	Boots Co Plc	Fluid dispenser

1999
- 1999-01-13 EP EP99870004A patent/EP1020233A1/fr not_active Withdrawn
2000
- 2000-01-12 PE PE2000000022A patent/PE20001192A1/es not_active Application Discontinuation
- 2000-01-12 CA CA002360411A patent/CA2360411A1/fr not_active Abandoned
- 2000-01-12 EG EG20000030A patent/EG22672A/xx active
- 2000-01-12 CZ CZ20012506A patent/CZ20012506A3/cs unknown
- 2000-01-12 JP JP2000593418A patent/JP4295437B2/ja not_active Expired - Lifetime
- 2000-01-12 WO PCT/US2000/000834 patent/WO2000041816A1/fr not_active Ceased
- 2000-01-12 DE DE60004780T patent/DE60004780T2/de not_active Expired - Lifetime
- 2000-01-12 PL PL00349767A patent/PL349767A1/xx unknown
- 2000-01-12 CO CO00001231A patent/CO5231171A1/es not_active Application Discontinuation
- 2000-01-12 IL IL14409200A patent/IL144092A0/xx unknown
- 2000-01-12 KR KR1020017008745A patent/KR20020004944A/ko not_active Ceased
- 2000-01-12 AU AU25046/00A patent/AU748289B2/en not_active Ceased
- 2000-01-12 BR BR0007526-4A patent/BR0007526A/pt not_active IP Right Cessation
- 2000-01-12 HU HU0105057A patent/HUP0105057A3/hu unknown
- 2000-01-12 SK SK1006-2001A patent/SK10062001A3/sk unknown
- 2000-01-12 AT AT00903272T patent/ATE248030T1/de not_active IP Right Cessation
- 2000-01-12 RU RU2001122593/12A patent/RU2198740C1/ru not_active IP Right Cessation
- 2000-01-12 CN CN00802613A patent/CN1347346A/zh active Pending
- 2000-01-12 EP EP00903272A patent/EP1140368B1/fr not_active Expired - Lifetime
- 2000-01-12 NZ NZ512600A patent/NZ512600A/xx unknown
2001
- 2001-06-27 ZA ZA200105289A patent/ZA200105289B/en unknown
- 2001-07-11 MA MA26264A patent/MA25341A1/fr unknown
- 2001-07-13 NO NO20013508A patent/NO20013508D0/no not_active Application Discontinuation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101498220B1 (ko) *	2013-08-30	2015-03-03	삼성중공업 주식회사	체결부 부식방지용 실링 장치

Also Published As

Publication number	Publication date
AU748289B2 (en)	2002-05-30
CZ20012506A3 (cs)	2002-03-13
PE20001192A1 (es)	2000-12-04
EP1140368B1 (fr)	2003-08-27
JP2002534331A (ja)	2002-10-15
BR0007526A (pt)	2001-11-27
ZA200105289B (en)	2002-03-06
MA25341A1 (fr)	2001-12-31
CA2360411A1 (fr)	2000-07-20
NZ512600A (en)	2002-12-20
ATE248030T1 (de)	2003-09-15
IL144092A0 (en)	2002-05-23
CN1347346A (zh)	2002-05-01
PL349767A1 (en)	2002-09-09
RU2198740C1 (ru)	2003-02-20
RU2001122593A (ru)	2004-02-20
EP1140368A1 (fr)	2001-10-10
EG22672A (en)	2003-06-30
WO2000041816A1 (fr)	2000-07-20
EP1020233A1 (fr)	2000-07-19
NO20013508L (no)	2001-07-13
HUP0105057A2 (hu)	2002-04-29
AU2504600A (en)	2000-08-01
SK10062001A3 (sk)	2002-03-05
DE60004780D1 (de)	2003-10-02
JP4295437B2 (ja)	2009-07-15
CO5231171A1 (es)	2002-12-27
NO20013508D0 (no)	2001-07-13
HUP0105057A3 (en)	2002-06-28
DE60004780T2 (de)	2004-06-17

Legal Events

Date	Code	Title	Description
2001-07-11	A201	Request for examination
2001-07-11	PA0105	International application	Patent event date: 20010711 Patent event code: PA01051R01D Comment text: International Patent Application
2001-07-11	PA0201	Request for examination
2002-01-16	PG1501	Laying open of application
2003-07-24	E902	Notification of reason for refusal
2003-07-24	PE0902	Notice of grounds for rejection	Comment text: Notification of reason for refusal Patent event date: 20030724 Patent event code: PE09021S01D
2004-01-30	E601	Decision to refuse application
2004-01-30	PE0601	Decision on rejection of patent	Patent event date: 20040130 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20030724 Comment text: Notification of reason for refusal Patent event code: PE06011S01I

Publication	Publication Date	Title
KR20020004944A (ko)	2002-01-16	정량조절 및 배출 장치
US6471095B1 (en)	2002-10-29	Dosing and delivering system
EP1779933A1 (fr)	2007-05-02	Distributeur de liquide
AU751624B2 (en)	2002-08-22	Nasal spray device with elastomeric valve
AU749158B2 (en)	2002-06-20	Nasal spray device with improved spray geometry
MXPA01007126A (en)	2002-03-05	Dosing and delivering system
MX2008005432A (en)	2008-10-03	Dispenser for a liquid
MXPA00009620A (en)	2001-07-31	Nasal spray device with elastomeric valve

KR20020004944A - 정량조절 및 배출 장치 - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (3)

Publications (1)

Family

ID=8243788

Family Applications (1)

Country Status (23)

Cited By (1)

Families Citing this family (25)

Family Cites Families (12)

Cited By (1)

Also Published As

Similar Documents

Legal Events